Rico-Fontalvo J, Daza-Arnedo R, Cabrales J, Montejo-Hernández JD. Semaglutide in Overweight and Obese patients: Cardiovascular and/or Renal Metabolic Benefits . Rev. Colomb. Nefrol. [Internet]. 2022 Oct. 14 [cited 2024 Apr. 20];9(3). Available from: https://revistanefrologia.org/index.php/rcn/article/view/614